SoftBank Group Corp. will sell its chip designer Arm, a vital supplier to Apple Inc., to Nvidia Corp. for as much as $40 billion.
Nvidia will pay SoftBank $12 billion in cash and $21.5 billion in shares.
SoftBank and the Vision Fund, which has a 25 percent stake in Arm, will take a stake in Nvidia of between 6.7 and 8.1 percent.
Brisk business performance could earn SoftBank an additional $5 billion in cash or Nvidia shares and Arm employees $1.5 billion in shares.
SoftBank CEO Masayoshi Son had been praising Arm for its potential but has since been slashing his stakes.
The sale marks an early exit for SoftBank in the British chip technology firm, just four years after its $32 billion acquisition.
The Arm acquisition puts vital suppliers across the industry under the control of Nvidia.
Arm licenses its chip designs and technology the likes of Qualcomm Inc, Apple, and Samsung Electronics Co. Ltd.
Forthcoming Mac computers are also slated to use chips from Arm.
Nvidia CEO Jensen Huang intends to retain Arm’s neutral licensing model and license out Nvidia's graphical processor unit through Arm’s silicon partners.
A new artificial intelligence research center will be built at Arm’s Cambridge headquarters.
With the acquisition, Nvidia anticipates more intense competition from data center chip rivals such as Advanced Micro Devices Inc. and Intel Corp.


Standard Chartered Beats Profit Forecasts as First-Half Earnings Rise 9%
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline
BHP, Port Hedland Unions Fail to Reach Wage Deal as Negotiations Continue
Zhongji Innolight Raises $6.8 Billion in Hong Kong IPO as AI Demand Fuels Growth
Meta CEO Zuckerberg Opposes U.S. Ban on Chinese AI Models, Warns Against Overregulation
ASML, Applied Materials Slide as China DUV Chip Equipment Breakthrough Sparks Market Jitters
Barclays Q2 Profit Beats Forecasts as Investment Banking Strength Offsets Higher Costs
SK Hynix Q2 Profit Hits Record as AI Memory Chip Demand Fuels Growth
AstraZeneca Q2 Earnings Beat Forecasts as Oncology Growth Supports 2026 Outlook
Sika Raises 2026 Sales Outlook After Strong First-Half Results Beat Expectations
Unilever Raises 2026 Sales Outlook After Strong Q2 Volume Growth
Exosens H1 Profit Beats Forecasts as Defense Demand Drives Growth
Zabka Shares Drop 10% as Seven & i Abandons Investment Plans
Philips Shares Slide 10% Despite Earnings Beat as Weak Orders Raise Growth Concerns
Nvidia Invests $1 Billion in Naver as South Korea AI Data Center Expansion Gains Momentum
Brown-Forman Rejects Sazerac’s $15 Billion Takeover Bid as Family Backs Independence 



